maropitant has been researched along with Canine Diseases in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 16 (59.26) | 24.3611 |
| 2020's | 7 (25.93) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, PJ; McKee, TS; Moyer, AL; Vinayak, A | 1 |
| Burke, JE; Hess, RS; Silverstein, DC | 1 |
| Fukazawa, E; Harada, K; Ichimata, M; Kobayashi, T; Matsuyama, F; Nakano, Y | 1 |
| Bennett, KO; Bussieres, G; Collins, RJ; Ebner, LS; Gebert, JE; Hampton, CE; Kleine, SA; Knych, HK; Mochel, JP; Mulon, PY; Seddighi, R; Smith, CK; Smith, JS | 1 |
| Chi, TT; Hay Kraus, BL | 1 |
| Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C | 1 |
| Glanemann, B; McCormack, R; Olley, L; Swann, JW | 1 |
| Dugdale, A; Elmer, T; Rioja, E; Swallow, A | 1 |
| Cartagena-Albertus, JC; Engel Manchado, J; Moise, A; Montoya Alonso, JA; Moya García, S | 1 |
| Fransson, BA; Jones, CT | 1 |
| Johnson, RA | 1 |
| Cooke, K; Isaza, N; Koh, RB; Robertson, SA; Xie, H | 1 |
| Borrego, JF; Huelsmeyer, MK; Kurzman, ID; Miller, SA; Muszynski, JL; Pinkerton, ME; Vail, DM | 1 |
| Hay Kraus, BL | 3 |
| Blackwood, L; Cripps, P; Elliott, J; Grant, IA; Mason, SL | 1 |
| Grobman, M; Reinero, C | 1 |
| Borsch, C; Clemence, R; Failing, K; Fink, T; Kunz, C; Neiger, R; Savary-Bataille, K; Schmitz, S | 1 |
| Himelfarb, MA; Invaldi, SH; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP | 1 |
| Keser, GO; Yalcin, E | 1 |
| Aleo, M; Coscarelli, E; Fleck, T; Galvan, B; Humphrey, W; McCall, RB; Narishetty, ST | 1 |
| Shukla, A | 1 |
| Alibhai, HI; Lee, K; Mathis, A | 1 |
| Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Tilt, N | 1 |
| Benchaoui, HA; Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Siedek, EM; Tilt, N | 2 |
18 trial(s) available for maropitant and Canine Diseases
| Article | Year |
|---|---|
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromorphone; Nausea; Ondansetron; Quinuclidines; Vomiting | 2021 |
Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Topics: Animals; Antiemetics; Antifibrinolytic Agents; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Ondansetron; Prospective Studies; Quinuclidines; Tranexamic Acid; Vomiting | 2020 |
The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Isoflurane; Ovariectomy; Postoperative Nausea and Vomiting; Quinuclidines | 2017 |
Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.
Topics: Animals; Antidiarrheals; Antiemetics; Antineoplastic Agents, Phytogenic; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Loperamide; Male; Neoplasms; Paclitaxel; Quinuclidines; Random Allocation; Vomiting | 2019 |
Evaluation of the effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux in dogs.
Topics: Animals; Dog Diseases; Dogs; Dopamine D2 Receptor Antagonists; Female; Gastroesophageal Reflux; Male; Metoclopramide; Postoperative Care; Quinuclidines | 2019 |
Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
Topics: Acepromazine; Analgesics, Opioid; Anesthesia, Inhalation; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Esophagus; Female; Gastroesophageal Reflux; Hydrogen-Ion Concentration; Hydromorphone; Male; Quinuclidines; Vomiting | 2014 |
Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Electroacupuncture; Female; Male; Morphine; Quinuclidines; Vomiting | 2014 |
Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Male; Quinuclidines; Vomiting | 2014 |
Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
Topics: Animals; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Lymphoma; Male; Quinuclidines; Vincristine | 2014 |
Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Drug Administration Schedule; Female; Hydromorphone; Male; Nausea; Quinuclidines; Vomiting | 2014 |
Effects of the neurokinin-1 antagonist maropitant on canine gastric emptying assessed by radioscintigraphy and breath test.
Topics: Animals; Breath Tests; Cisapride; Cross-Over Studies; Dog Diseases; Dogs; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Neurokinin-1 Receptor Antagonists; Quinuclidines; Radionuclide Imaging | 2016 |
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Male; Metoclopramide; Morphine; Nausea; Orchiectomy; Ovariectomy; Quinuclidines; Vomiting | 2017 |
Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Female; Male; Metoclopramide; Ondansetron; Parvoviridae Infections; Parvovirus, Canine; Quinuclidines; Treatment Outcome; Vomiting | 2017 |
Effect of refrigeration of the antiemetic Cerenia (maropitant) on pain on injection.
Topics: Animals; Antiemetics; beta-Cyclodextrins; Dog Diseases; Dogs; Excipients; Pain; Quinuclidines; Refrigeration | 2009 |
Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Injections, Intramuscular; Male; Preanesthetic Medication; Quinuclidines; Vomiting | 2013 |
Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dog Diseases; Dogs; Female; Least-Squares Analysis; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2007 |
The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Europe; Female; Male; Quinuclidines; Treatment Outcome; Vomiting | 2007 |
Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.
Topics: Animals; Antiemetics; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Motion Sickness; Quinuclidines; Treatment Outcome; Vomiting | 2007 |
9 other study(ies) available for maropitant and Canine Diseases
| Article | Year |
|---|---|
Low incidence of postoperative nausea, vomiting, regurgitation, and aspiration pneumonia in geriatric dogs receiving maropitant, famotidine, and fentanyl as part of an anesthesia protocol.
Topics: Anesthesia; Animals; Antiemetics; Dog Diseases; Dogs; Famotidine; Fentanyl; Incidence; Pneumonia, Aspiration; Postoperative Nausea and Vomiting; Quinuclidines | 2021 |
Evaluation of adverse events in small-breed dogs treated with maropitant and a single dose of doxorubicin.
Topics: Animals; Diarrhea; Dog Diseases; Dogs; Doxorubicin; Neoplasms; Neutropenia; Prospective Studies; Quinuclidines; Vomiting | 2022 |
Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus).
Topics: Animals; Antiemetics; Area Under Curve; Cat Diseases; Cats; Chromatography, Liquid; Dog Diseases; Dogs; Half-Life; Injections, Intramuscular; Rabbits; Sus scrofa; Swine; Swine Diseases; Tandem Mass Spectrometry | 2023 |
The effect of intravenous maropitant on blood pressure in healthy awake and anesthetized dogs.
Topics: Acepromazine; Anesthesia, Inhalation; Animals; Antiemetics; Blood Pressure; Dog Diseases; Dogs; Female; Heart Rate; Humans; Hypotension; Injections, Intravenous; Linear Models; Models, Animal; Premedication; Quinuclidines; Wakefulness | 2020 |
Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care.
Topics: Animals; Dog Diseases; Dogs; Drug Prescriptions; Gastrointestinal Diseases; Hospitalization; Omeprazole; Practice Patterns, Physicians'; Prospective Studies; Quinuclidines | 2020 |
Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.
Topics: Animals; Cell Line, Tumor; Dog Diseases; Dogs; Gene Expression Regulation, Neoplastic; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Neurokinin-1 Receptor Antagonists; Quinuclidines; Receptors, Neurokinin-1; RNA, Messenger | 2016 |
Investigation of Neurokinin-1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs.
Topics: Animals; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Cough; Dog Diseases; Dogs; Eosinophils; Female; Male; Neurokinin-1 Receptor Antagonists; Neutrophils; Quinuclidines | 2016 |
Acute pancreatitis attributed to dietary indiscretion in a female mixed breed canine.
Topics: Acute Disease; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Dehydration; Dog Diseases; Dogs; Female; Medical History Taking; Meloxicam; Pancreatitis; Quinuclidines; Radiography; Tachycardia; Thiazines; Thiazoles; Treatment Outcome; Vomiting | 2010 |
The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog.
Topics: Anesthesia, Epidural; Animals; Antiemetics; Dog Diseases; Dogs; Male; Morphine; Narcotics; Quinuclidines; Vomiting | 2011 |